Telemedicine: A promising future for inflammatory bowel disease management
- PMID: 36148081
- PMCID: PMC9486437
- DOI: 10.1016/j.amsu.2022.104684
Telemedicine: A promising future for inflammatory bowel disease management
Keywords: Developing countries; Disease burden; Health care.
Conflict of interest statement
The authors have no conflicts of interest.
Similar articles
-
Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial.Lancet. 2017 Sep 2;390(10098):959-968. doi: 10.1016/S0140-6736(17)31327-2. Epub 2017 Jul 14. Lancet. 2017. PMID: 28716313 Clinical Trial.
-
Real-life pilot study on the impact of the telemedicine platform EasyMICI-MaMICI® on quality of life and quality of care in patients with inflammatory bowel disease.Scand J Gastroenterol. 2021 May;56(5):530-536. doi: 10.1080/00365521.2021.1894602. Epub 2021 Mar 10. Scand J Gastroenterol. 2021. PMID: 33691075 Clinical Trial.
-
The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S6-S16. doi: 10.1093/jcag/gwy054. Epub 2018 Nov 2. J Can Assoc Gastroenterol. 2019. PMID: 31294381 Free PMC article.
-
The future of telemedicine and wearable technology in IBD.Curr Opin Gastroenterol. 2022 Jul 1;38(4):373-381. doi: 10.1097/MOG.0000000000000845. Curr Opin Gastroenterol. 2022. PMID: 35762696 Review.
-
[Telemedicine applications for monitoring inflammatory bowel disease and irritable bowel syndrome].Ugeskr Laeger. 2020 Feb 17;182(8):V10190588. Ugeskr Laeger. 2020. PMID: 32138819 Review. Danish.
References
-
- Craig J., Petterson V. Introduction to the practice of telemedicine. J. Telemed. Telecare. 2005 Jan;11(1):3–9. - PubMed
-
- Watermeyer G., Katsidzira L., Setshedi M., Devani S., Mudombi W., Kassianides C. Inflammatory bowel disease in sub-Saharan Africa: epidemiology, risk factors, and challenges in diagnosis. Lancet Gastroenterol. Hepatol. 2022 Jun 30 - PubMed
LinkOut - more resources
Full Text Sources